img

Global Urology Drugs Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Urology Drugs Market Insights, Forecast to 2034

Urology drugs used in the treatment of urogenital conditions and diseases.
Global Urology Drugs market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Urology Drugs industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2024, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers
This report presents an overview of global Urology Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Urology Drugs market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Astellas
Endo
GP Pharm
Tolmar
Segment by Type
Α (alpha) Blockers
5 α-reductase Inhibitors

Segment by Application


Hospital
Clinic
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Urology Drugs plant distribution, commercial date of Urology Drugs, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Urology Drugs introduction, etc. Urology Drugs Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Urology Drugs
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Urology Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Urology Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Α (alpha) Blockers
1.2.3 5 α-reductase Inhibitors
1.3 Market by Application
1.3.1 Global Urology Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Urology Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Urology Drugs Revenue by Region
2.2.1 Global Urology Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Urology Drugs Revenue by Region (2018-2024)
2.2.3 Global Urology Drugs Revenue by Region (2024-2029)
2.2.4 Global Urology Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Urology Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Urology Drugs Sales by Region
2.4.1 Global Urology Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Urology Drugs Sales by Region (2018-2024)
2.4.3 Global Urology Drugs Sales by Region (2024-2029)
2.4.4 Global Urology Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Urology Drugs Sales by Manufacturers
3.1.1 Global Urology Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Urology Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Urology Drugs in 2022
3.2 Global Urology Drugs Revenue by Manufacturers
3.2.1 Global Urology Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Urology Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Urology Drugs Revenue in 2022
3.3 Global Key Players of Urology Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Urology Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Urology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Urology Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Urology Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Urology Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Urology Drugs Sales by Type
4.1.1 Global Urology Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Urology Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Urology Drugs Sales Market Share by Type (2018-2029)
4.2 Global Urology Drugs Revenue by Type
4.2.1 Global Urology Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Urology Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Urology Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Urology Drugs Price by Type
4.3.1 Global Urology Drugs Price by Type (2018-2024)
4.3.2 Global Urology Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Urology Drugs Sales by Application
5.1.1 Global Urology Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Urology Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Urology Drugs Sales Market Share by Application (2018-2029)
5.2 Global Urology Drugs Revenue by Application
5.2.1 Global Urology Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Urology Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Urology Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Urology Drugs Price by Application
5.3.1 Global Urology Drugs Price by Application (2018-2024)
5.3.2 Global Urology Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Urology Drugs Market Size by Type
6.1.1 US & Canada Urology Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Urology Drugs Revenue by Type (2018-2029)
6.2 US & Canada Urology Drugs Market Size by Application
6.2.1 US & Canada Urology Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Urology Drugs Revenue by Application (2018-2029)
6.3 US & Canada Urology Drugs Market Size by Country
6.3.1 US & Canada Urology Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Urology Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Urology Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Urology Drugs Market Size by Type
7.1.1 Europe Urology Drugs Sales by Type (2018-2029)
7.1.2 Europe Urology Drugs Revenue by Type (2018-2029)
7.2 Europe Urology Drugs Market Size by Application
7.2.1 Europe Urology Drugs Sales by Application (2018-2029)
7.2.2 Europe Urology Drugs Revenue by Application (2018-2029)
7.3 Europe Urology Drugs Market Size by Country
7.3.1 Europe Urology Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Urology Drugs Sales by Country (2018-2029)
7.3.3 Europe Urology Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Urology Drugs Market Size
8.1.1 China Urology Drugs Sales (2018-2029)
8.1.2 China Urology Drugs Revenue (2018-2029)
8.2 China Urology Drugs Market Size by Application
8.2.1 China Urology Drugs Sales by Application (2018-2029)
8.2.2 China Urology Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Urology Drugs Market Size by Type
9.1.1 Asia Urology Drugs Sales by Type (2018-2029)
9.1.2 Asia Urology Drugs Revenue by Type (2018-2029)
9.2 Asia Urology Drugs Market Size by Application
9.2.1 Asia Urology Drugs Sales by Application (2018-2029)
9.2.2 Asia Urology Drugs Revenue by Application (2018-2029)
9.3 Asia Urology Drugs Sales by Region
9.3.1 Asia Urology Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Urology Drugs Revenue by Region (2018-2029)
9.3.3 Asia Urology Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Urology Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Urology Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Urology Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Urology Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Urology Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Urology Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Urology Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Urology Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Urology Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Urology Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Astellas
11.1.1 Astellas Company Information
11.1.2 Astellas Overview
11.1.3 Astellas Urology Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Astellas Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Astellas Recent Developments
11.2 Endo
11.2.1 Endo Company Information
11.2.2 Endo Overview
11.2.3 Endo Urology Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Endo Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Endo Recent Developments
11.3 GP Pharm
11.3.1 GP Pharm Company Information
11.3.2 GP Pharm Overview
11.3.3 GP Pharm Urology Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 GP Pharm Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GP Pharm Recent Developments
11.4 Tolmar
11.4.1 Tolmar Company Information
11.4.2 Tolmar Overview
11.4.3 Tolmar Urology Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Tolmar Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Tolmar Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Urology Drugs Industry Chain Analysis
12.2 Urology Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Urology Drugs Production Mode & Process
12.4 Urology Drugs Sales and Marketing
12.4.1 Urology Drugs Sales Channels
12.4.2 Urology Drugs Distributors
12.5 Urology Drugs Customers
13 Market Dynamics
13.1 Urology Drugs Industry Trends
13.2 Urology Drugs Market Drivers
13.3 Urology Drugs Market Challenges
13.4 Urology Drugs Market Restraints
14 Key Findings in The Global Urology Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Urology Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Α (alpha) Blockers
Table 3. Major Manufacturers of 5 α-reductase Inhibitors
Table 4. Global Urology Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Urology Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Urology Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Urology Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Urology Drugs Revenue Market Share by Region (2018-2024)
Table 9. Global Urology Drugs Revenue Market Share by Region (2024-2029)
Table 10. Global Urology Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Urology Drugs Sales by Region (2018-2024) & (MT)
Table 12. Global Urology Drugs Sales by Region (2024-2029) & (MT)
Table 13. Global Urology Drugs Sales Market Share by Region (2018-2024)
Table 14. Global Urology Drugs Sales Market Share by Region (2024-2029)
Table 15. Global Urology Drugs Sales by Manufacturers (2018-2024) & (MT)
Table 16. Global Urology Drugs Sales Share by Manufacturers (2018-2024)
Table 17. Global Urology Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Urology Drugs Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Urology Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Urology Drugs Price by Manufacturers 2018-2024 (USD/Kg)
Table 21. Global Urology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Urology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urology Drugs as of 2022)
Table 23. Global Key Manufacturers of Urology Drugs, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Urology Drugs, Product Offered and Application
Table 25. Global Key Manufacturers of Urology Drugs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Urology Drugs Sales by Type (2018-2024) & (MT)
Table 28. Global Urology Drugs Sales by Type (2024-2029) & (MT)
Table 29. Global Urology Drugs Sales Share by Type (2018-2024)
Table 30. Global Urology Drugs Sales Share by Type (2024-2029)
Table 31. Global Urology Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Urology Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Urology Drugs Revenue Share by Type (2018-2024)
Table 34. Global Urology Drugs Revenue Share by Type (2024-2029)
Table 35. Urology Drugs Price by Type (2018-2024) & (USD/Kg)
Table 36. Global Urology Drugs Price Forecast by Type (2024-2029) & (USD/Kg)
Table 37. Global Urology Drugs Sales by Application (2018-2024) & (MT)
Table 38. Global Urology Drugs Sales by Application (2024-2029) & (MT)
Table 39. Global Urology Drugs Sales Share by Application (2018-2024)
Table 40. Global Urology Drugs Sales Share by Application (2024-2029)
Table 41. Global Urology Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Urology Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Urology Drugs Revenue Share by Application (2018-2024)
Table 44. Global Urology Drugs Revenue Share by Application (2024-2029)
Table 45. Urology Drugs Price by Application (2018-2024) & (USD/Kg)
Table 46. Global Urology Drugs Price Forecast by Application (2024-2029) & (USD/Kg)
Table 47. US & Canada Urology Drugs Sales by Type (2018-2024) & (MT)
Table 48. US & Canada Urology Drugs Sales by Type (2024-2029) & (MT)
Table 49. US & Canada Urology Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Urology Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Urology Drugs Sales by Application (2018-2024) & (MT)
Table 52. US & Canada Urology Drugs Sales by Application (2024-2029) & (MT)
Table 53. US & Canada Urology Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Urology Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Urology Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Urology Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Urology Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Urology Drugs Sales by Country (2018-2024) & (MT)
Table 59. US & Canada Urology Drugs Sales by Country (2024-2029) & (MT)
Table 60. Europe Urology Drugs Sales by Type (2018-2024) & (MT)
Table 61. Europe Urology Drugs Sales by Type (2024-2029) & (MT)
Table 62. Europe Urology Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Urology Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Urology Drugs Sales by Application (2018-2024) & (MT)
Table 65. Europe Urology Drugs Sales by Application (2024-2029) & (MT)
Table 66. Europe Urology Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Urology Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Urology Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Urology Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Urology Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Urology Drugs Sales by Country (2018-2024) & (MT)
Table 72. Europe Urology Drugs Sales by Country (2024-2029) & (MT)
Table 73. China Urology Drugs Sales by Type (2018-2024) & (MT)
Table 74. China Urology Drugs Sales by Type (2024-2029) & (MT)
Table 75. China Urology Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Urology Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Urology Drugs Sales by Application (2018-2024) & (MT)
Table 78. China Urology Drugs Sales by Application (2024-2029) & (MT)
Table 79. China Urology Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Urology Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Urology Drugs Sales by Type (2018-2024) & (MT)
Table 82. Asia Urology Drugs Sales by Type (2024-2029) & (MT)
Table 83. Asia Urology Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Urology Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Urology Drugs Sales by Application (2018-2024) & (MT)
Table 86. Asia Urology Drugs Sales by Application (2024-2029) & (MT)
Table 87. Asia Urology Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Urology Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Urology Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Urology Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Urology Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Urology Drugs Sales by Region (2018-2024) & (MT)
Table 93. Asia Urology Drugs Sales by Region (2024-2029) & (MT)
Table 94. Middle East, Africa and Latin America Urology Drugs Sales by Type (2018-2024) & (MT)
Table 95. Middle East, Africa and Latin America Urology Drugs Sales by Type (2024-2029) & (MT)
Table 96. Middle East, Africa and Latin America Urology Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Urology Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Urology Drugs Sales by Application (2018-2024) & (MT)
Table 99. Middle East, Africa and Latin America Urology Drugs Sales by Application (2024-2029) & (MT)
Table 100. Middle East, Africa and Latin America Urology Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Urology Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Urology Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Urology Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Urology Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Urology Drugs Sales by Country (2018-2024) & (MT)
Table 106. Middle East, Africa and Latin America Urology Drugs Sales by Country (2024-2029) & (MT)
Table 107. Astellas Company Information
Table 108. Astellas Description and Major Businesses
Table 109. Astellas Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 110. Astellas Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Astellas Recent Developments
Table 112. Endo Company Information
Table 113. Endo Description and Major Businesses
Table 114. Endo Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 115. Endo Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Endo Recent Developments
Table 117. GP Pharm Company Information
Table 118. GP Pharm Description and Major Businesses
Table 119. GP Pharm Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 120. GP Pharm Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. GP Pharm Recent Developments
Table 122. Tolmar Company Information
Table 123. Tolmar Description and Major Businesses
Table 124. Tolmar Urology Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 125. Tolmar Urology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Tolmar Recent Developments
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Urology Drugs Distributors List
Table 130. Urology Drugs Customers List
Table 131. Urology Drugs Market Trends
Table 132. Urology Drugs Market Drivers
Table 133. Urology Drugs Market Challenges
Table 134. Urology Drugs Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Urology Drugs Product Picture
Figure 2. Global Urology Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Urology Drugs Market Share by Type in 2022 & 2029
Figure 4. Α (alpha) Blockers Product Picture
Figure 5. 5 α-reductase Inhibitors Product Picture
Figure 6. Global Urology Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Urology Drugs Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Urology Drugs Report Years Considered
Figure 12. Global Urology Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Urology Drugs Revenue 2018-2029 (US$ Million)
Figure 14. Global Urology Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Urology Drugs Revenue Market Share by Region (2018-2029)
Figure 16. Global Urology Drugs Sales 2018-2029 ((MT)
Figure 17. Global Urology Drugs Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Urology Drugs Sales YoY (2018-2029) & (MT)
Figure 19. US & Canada Urology Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Urology Drugs Sales YoY (2018-2029) & (MT)
Figure 21. Europe Urology Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Urology Drugs Sales YoY (2018-2029) & (MT)
Figure 23. China Urology Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Urology Drugs Sales YoY (2018-2029) & (MT)
Figure 25. Asia (excluding China) Urology Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Urology Drugs Sales YoY (2018-2029) & (MT)
Figure 27. Middle East, Africa and Latin America Urology Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Urology Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Urology Drugs in the World: Market Share by Urology Drugs Revenue in 2022
Figure 30. Global Urology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Urology Drugs Sales Market Share by Type (2018-2029)
Figure 32. Global Urology Drugs Revenue Market Share by Type (2018-2029)
Figure 33. Global Urology Drugs Sales Market Share by Application (2018-2029)
Figure 34. Global Urology Drugs Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Urology Drugs Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Urology Drugs Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Urology Drugs Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Urology Drugs Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Urology Drugs Revenue Share by Country (2018-2029)
Figure 40. US & Canada Urology Drugs Sales Share by Country (2018-2029)
Figure 41. U.S. Urology Drugs Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Urology Drugs Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Urology Drugs Sales Market Share by Type (2018-2029)
Figure 44. Europe Urology Drugs Revenue Market Share by Type (2018-2029)
Figure 45. Europe Urology Drugs Sales Market Share by Application (2018-2029)
Figure 46. Europe Urology Drugs Revenue Market Share by Application (2018-2029)
Figure 47. Europe Urology Drugs Revenue Share by Country (2018-2029)
Figure 48. Europe Urology Drugs Sales Share by Country (2018-2029)
Figure 49. Germany Urology Drugs Revenue (2018-2029) & (US$ Million)
Figure 50. France Urology Drugs Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Urology Drugs Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Urology Drugs Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Urology Drugs Revenue (2018-2029) & (US$ Million)
Figure 54. China Urology Drugs Sales Market Share by Type (2018-2029)
Figure 55. China Urology Drugs Revenue Market Share by Type (2018-2029)
Figure 56. China Urology Drugs Sales Market Share by Application (2018-2029)
Figure 57. China Urology Drugs Revenue Market Share by Application (2018-2029)
Figure 58. Asia Urology Drugs Sales Market Share by Type (2018-2029)
Figure 59. Asia Urology Drugs Revenue Market Share by Type (2018-2029)
Figure 60. Asia Urology Drugs Sales Market Share by Application (2018-2029)
Figure 61. Asia Urology Drugs Revenue Market Share by Application (2018-2029)
Figure 62. Asia Urology Drugs Revenue Share by Region (2018-2029)
Figure 63. Asia Urology Drugs Sales Share by Region (2018-2029)
Figure 64. Japan Urology Drugs Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Urology Drugs Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Urology Drugs Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Urology Drugs Revenue (2018-2029) & (US$ Million)
Figure 68. India Urology Drugs Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Urology Drugs Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Urology Drugs Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Urology Drugs Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Urology Drugs Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Urology Drugs Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Urology Drugs Sales Share by Country (2018-2029)
Figure 75. Brazil Urology Drugs Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Urology Drugs Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Urology Drugs Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Urology Drugs Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Urology Drugs Revenue (2018-2029) & (US$ Million)
Figure 80. Urology Drugs Value Chain
Figure 81. Urology Drugs Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed